Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

A Self-Management Program for Adults With Both Schizophrenia and a Co-occurring Medical Condition

23. august 2019 oppdatert av: Richard Goldberg, University of Maryland, Baltimore

Optimizing Chronic Illness Self-Management for Individuals With Schizophrenia

This study will develop and evaluate the effectiveness of a self-management program for adults living with both schizophrenia and a co-occurring medical condition.

Studieoversikt

Status

Fullført

Forhold

Detaljert beskrivelse

Schizophrenia is a life-long brain disorder affecting approximately 1 percent of Americans each year. Schizophrenia can be extremely disabling, causing people to hear voices, experience paranoia or hallucinations, and believe that others are controlling their thoughts. People with schizophrenia also experience increased rates of concurrent medical conditions, such as diabetes, respiratory illness, and heart disease. This can make holding a job or even caring for oneself very difficult. The purpose of this study is to develop and evaluate a self-management program for adults living with both schizophrenia and a concurrent medical condition.

Participants in this open-label study will attend 10 to 16 group sessions led by two group leaders. Group sessions will meet each week for an hour during which participants will learn new skills to help them take responsibility for the daily management of chronic medical conditions. In addition to learning how to communicate more effectively with medical providers, participants will learn about healthy eating, the importance of physical activity, addictive behaviors that can worsen health conditions, and proper use of medications. Homework will be assigned weekly for participants to review skills learned in each session. After each session, participants will complete a survey to evaluate the session's effectiveness. At the end of the study, participants will attend one additional group meeting and an individual interview to discuss the overall effectiveness of the intervention and their experiences in the group sessions. The results of this study will be used to evaluate and improve the self-management program for future use.

Studietype

Intervensjonell

Registrering (Faktiske)

100

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Maryland
      • Baltimore, Maryland, Forente stater, 21201
        • Fayette Street Clinics

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 64 år (Voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Meets DSM-IV criteria for schizophrenia or schizoaffective disorder
  • Current documented chart diagnosis of at least one chronic medical condition
  • Received clinic services for a minimum of 3 months prior to study entry
  • English-speaking
  • Willing to use an effective form of birth control throughout the study if sexually active

Exclusion Criteria:

  • History of a serious neurological disorder or head trauma with loss of consciousness
  • Diagnosed with mental retardation or dementia
  • Diagnosed with end stage organ disease
  • Currently receiving chemotherapy and/or radiation treatment for cancer
  • Received psychiatric hospitalization less than 3 months prior to study entry date
  • Blind and/or deaf
  • Pregnant
  • Infected with HIV with a CD4 count under 350
  • Diagnosis of AIDS
  • Diagnosis of anorexia
  • Problematic substance use, as defined by a mental health provider
  • Psychiatric instability, as defined by a mental health provider

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: 1
Participants will receive a self-management program for chronic illness
Self-management program for chronic illness will include between 10 and 16 psychoeducational and supportive group sessions.
Ingen inngripen: Usaual Care
Usual Care; no additional intervention

Hva måler studien?

Primære resultatmål

Resultatmål
Tidsramme
Health-related self-efficacy and recovery orientation
Tidsramme: Measured at pre- and post-intervention
Measured at pre- and post-intervention
Medical illness self-management skills
Tidsramme: Measured at pre- and post-intervention
Measured at pre- and post-intervention
Social and communication skills during interactions with health care providers
Tidsramme: Measured at pre- and post-intervention
Measured at pre- and post-intervention
Physical and mental health status
Tidsramme: Measured at pre- and post-intervention
Measured at pre- and post-intervention
Medical service use patterns
Tidsramme: Measured at pre- and post-intervention
Measured at pre- and post-intervention

Sekundære resultatmål

Resultatmål
Tidsramme
Medication use
Tidsramme: Measured throughout the study
Measured throughout the study
Neurocognition
Tidsramme: Measured at baseline
Measured at baseline
Substance abuse
Tidsramme: Measured at pre- and post-intervention
Measured at pre- and post-intervention
Psychiatric symptoms
Tidsramme: Measured at pre- and post-intervention
Measured at pre- and post-intervention
Amount and seriousness of related comorbidities
Tidsramme: Measured at pre- and post-intervention
Measured at pre- and post-intervention
Quantitative and qualitative survey ratings
Tidsramme: Measured throughout the study
Measured throughout the study

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Richard W. Goldberg, PhD, University of Maryland, College Park

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. september 2007

Primær fullføring (Faktiske)

1. mai 2015

Studiet fullført (Faktiske)

1. mai 2015

Datoer for studieregistrering

Først innsendt

4. september 2007

Først innsendt som oppfylte QC-kriteriene

4. september 2007

Først lagt ut (Anslag)

5. september 2007

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

28. august 2019

Siste oppdatering sendt inn som oppfylte QC-kriteriene

23. august 2019

Sist bekreftet

1. august 2019

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • HP-00040526
  • DAHBR 96-BHB
  • R34MH078168 (U.S. NIH-stipend/kontrakt)

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere